glp 1 receptor agonist moa Frontiers Frontiers | Mini Review: Effect
Description
CTL: cytotoxic T lymphocyte
Its weight-reducing effects are particularly notable, offering a promising option for patients with concomitant obesity, a common comorbidity in T2D
S.,Yun, H., Yu, O
(), , trend or significant increment in this parameter (weak, intermediate, or strong effect)
Nowell J, Blunt E, Gupta D, Edison P
C.AtkinS
